Transcept Pharma (TSPT) Swings to Q4 Profit of 37c/Share

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) reported Q4 EPS of $0.37, versus ($0.20) reported last year. Revenue for the quarter came in at $12.8 million, versus $3.13 million reported last year.

For earnings history and earnings-related data on Transcept Pharmaceuticals, Inc. (TSPT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Fermi Inc. (FRMI) Reports Q2 Loss of $0.04
• Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance